PEN - Penumbra, Inc.
| Previous Close | 152.95 |
| Open | 152.70 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 151.55 - 155.70 |
| 52 Week Range | 82.55 - 167.35 |
| Volume | 259,746 |
| Avg. Volume | 401,195 |
| Market Cap | 5.231B |
| Beta | 0.08 |
| PE Ratio (TTM) | 202.60 |
| EPS (TTM) | 0.75 |
| Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 166.60 |
Markit•19 hours agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $2.75 billion over the last one-month.
Markit•4 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding PEN are favorable, with net inflows of $3.11 billion.
- Zacks•4 days ago
AngioDynamics (ANGO) to Acquire RadiaDyne, Boost Oncology
AngioDynamics' (ANGO) agreement to acquire RadiaDyne is expected to close by the end of September. The RadiaDyne acquisition will expand the Oncology segment.
- Zacks•5 days ago
DENTSPLY Launches Azento, Improves Digital Implant Workflow
DENTSPLY's (XRAY) Azento is a unique dental platform that will help dentists select the best-fitting implant, optimal implant positioning and feasible healing environment.
- Zacks•6 days ago
Here's Why You Should Invest in Penumbra (PEN) Stock Now
The market is quite upbeat about Penumbra's (PEN) recently-closed buyout of a controlling stake in MVI Health, aimed at capturing the great potential of virtual reality application.
- Zacks•6 days ago
Allscripts' Sunrise Abstracting Selected by Wyckoff Heights
Allscripts' (MDRX) Sunrise Abstracting Solution gets picked by Wyckoff Heights Medical Center. The platform complements Allscripts Sunrise electronic health record unit.
- Zacks•7 days ago
Here's Why You Should Hold On to DaVita (DVA) Stock Now
Strong prospects in the Kidney Care segment to drive DaVita (DVA) stock over the long haul.
- Simply Wall St.•7 days ago
Shareholders Should Check If Insiders Own Shares In Penumbra Inc (NYSE:PEN)
Every investor in Penumbra Inc (NYSE:PEN) should be aware of the most powerful shareholder groups. Institutions will often hold stock in bigger companies, and we expect to see insiders owningRead More...
- Zacks•9 days ago
Thermo Fisher to Acquire BD's Advanced Bioprocessing Unit
BD's (BDX) Advanced Bioprocessing business generates revenues worth $100 million annually. The unit will be integrated in the Thermo Fisher's (TMO) Life Sciences Solutions Segment.
- Markit•11 days ago
See what the IHS Markit Score report has to say about Penumbra Inc.
Short interest is low for PEN with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ETFs that hold PEN had net inflows of $2.72 billion over the last one-month.
- Zacks•12 days ago
OPKO Health (OPK) Begins RAYALDEE Phase 2 Clinical Trial
OPKO Health's (OPK) consistent focus on enhancing the efficacy of its flagship RAYALDEE platform is likely to lend it a competitive edge in the MedTech space.
- Thomson Reuters StreetEvents•13 days ago
Edited Transcript of PEN earnings conference call or presentation 7-Aug-18 8:30pm GMT
Q2 2018 Penumbra Inc Earnings Call
- Zacks•13 days ago
Penumbra Launches Reperfusion Catheters, Boosts Neuro Unit
Penumbra (PEN) adopts initiatives to boost the highest revenue generating Neuro business.
- Zacks•13 days ago
Neogen's Livestock Genetic Buyout Expands Animal Safety Suite
The acquisition of Livestock Genetic will position Neogen (NEOG) as a leading agrigenomics company worldwide.
Markit•13 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Markit•15 days agoSee what the IHS Markit Score report has to say about Penumbra Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, ETFs holding PEN are favorable, with net inflows of $3.08 billion.
- Business Wire•15 days ago
Penumbra, Inc. Announces Acquisition of Controlling Interest in MVI Health
Penumbra, Inc. (PEN), a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90 percent of the equity of MVI Health for $20 million in upfront cash consideration. MVI Health, originally formed in May 2017, is a joint venture between Penumbra and Sixense Enterprises, a leader in virtual reality software and tracking solutions for enterprise. Since its founding, MVI Health has been developing virtual reality technology for healthcare applications.
- Business Wire•15 days ago
Penumbra Launches Latest Advancements in Stroke Thrombectomy Aspiration Technology
All are part of the fully integrated Penumbra System® that utilizes aspiration-based mechanical thrombectomy for stroke revascularization. The Penumbra JET 7 and JET D Reperfusion Catheters deliver deep vacuum aspiration power of the Penumbra ENGINE to enable physicians to extract thrombus effectively and safely in acute ischemic stroke patients.
- Zacks•19 days ago
Stryker (SYK) to Acquire K2M Group, Fortify Spine Division
Post the acquisition, Stryker (SYK) will leverage on K2M Group's (KTWO) complex spine and minimally invasive solutions.
- Zacks•22 days ago
Here's Why You Should Hold On to DexCom (DXCM) Stock Now
DexCom (DXCM) is expected to benefit from lucrative prospects in the diabetes market. However, the company's margins were under pressure in the last reported quarter.
- Zacks•25 days ago
Here's Why You Should Invest in Integer (ITGR) Stock Now
Integer Holdings (ITGR) gains on strong quarterly performance. The company is likely to gain from the Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets.
- Zacks•26 days ago
Cerner, Duke Clinical Research Launch Risk Calculator App
Cerner (CERN) launches new Risk Calculator app that will check cardiac risk. The company's relentless efforts to digitize its EHR systems is commendable.
- PR Newswire•27 days ago
Penumbra, Inc. Announces Participation at Upcoming Investor Conferences
ALAMEDA, Calif. , Aug. 22, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following upcoming investor conferences: Event: ...
- Zacks•29 days ago
Penumbra Sees Hammer Chart Pattern: Time to Buy?
Penumbra has been struggling lately, but the selling pressure may be coming to an end soon.
- Zacks•last month
Penumbra (PEN) Q2 Earnings & Revenues Top Estimates, View Up
Penumbra (PEN) benefits from strong growth across all geographies and product lines in Q2.
